NF2 and mesothelioma: NF2 mRNA was reported to have splicing variants, and the same study indicated that the carboxyl-terminal variant (isoform 2), which may not have tumor suppressive activity, is more significantly expressed in mesothelioma (Thurneysen et al., 2009).